AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting

AlpVision

PR86548

 

VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire=KYODO JBN/ --

 

On November 13th, 2020, AlpVision is launching the "AlpVision COVID-19

Initiative" helping pharmaceutical companies to protect COVID-19 relevant

medicines against counterfeiting.

 

COVID-19 has caused not only a worldwide health crisis, but also created

unprecedented economic challenges. In response, AlpVision has decided to launch

the "AlpVision COVID-19 Initiative". The initiative supports pharmaceutical

companies by providing them for free with the necessary tools to protect

COVID-19 relevant medicines and vaccines against counterfeiting.

 

To do so, AlpVision will provide pharmaceutical companies and their suppliers

with all necessary tools to deploy the Cryptoglyph on their packaging. The

AlpVision Cryptoglyph [https://alpvision.com/brand-protection/#cryptoglyph]is a

digital security feature which can be implemented and deployed within just a

few weeks. The Cryptoglyph is invisible to the human eye and authentication of

a product protected with a Cryptoglyph is done using a regular smartphone.

Securing of packaging with a Cryptoglyph is very easy as it neither changes the

standard production process, nor requires additional consumables. In addition,

the smartphone applications connect to AlpVision's Brand Monitoring System

(BMS)[https://alpvision.com/brand-protection/#bms], a centralized server

platform through which pharmaceutical companies are able to monitor in

real-time product authentication activities and gain important insight into

counterfeiting activities.

 

The "AlpVision COVID-19 Initiative" starts on November 13th, 2020, and

subscription will run for an initial period of three months. Participating

companies will be able to protect their COVID-19 relevant products with zero

additional cost for the authentication feature. AlpVision will provide this

service gratuitously until the pandemic is officially declared as ended by the

World Health Organization. Companies interested in participating in the

initiative are invited to contact AlpVision. More information can be found

online at www.alpvision.com/Covid/.

 

ALPVISION – MORE THAN ANTI-COUNTERFEIT SOLUTIONS

 

AlpVision was founded in 2001 and is the world's leader in digital

anti-counterfeiting technologies for product authentication and counterfeit

protection. AlpVision's digital anti-counterfeiting solutions for product

authentication are applicable to a wide variety of items, including packaging

and labelling, plastic and metal products, and high-value documents. AlpVision

anti-counterfeiting solutions are commercialized worldwide under license

agreements as entirely customizable turnkey computerized systems. Today

AlpVision protects over 30 billion of products each year.

More information is available at www.alpvision.com.

Join us on LinkedIn [https://linkedin.com/company/alpvision ] and

follow us on Twitter [https://twitter.com/alpvision].

 

Cryptoglyph and AlpVision are registered trademarks of AlpVision SA. Smart

Embossing, AlpVision Fingerprint® and Krypsos are trademarks of AlpVision SA.

 

Contact:

Martin Kutter

+41 21 948 6464  

avinfo-20@alpvision.com

 

Photo - https://mma.prnewswire.com/media/1332078/AlpVision_Authentication.jpg 

Logo - https://mma.prnewswire.com/media/1332077/AlpVision_Logo.jpg 

 

Source:  AlpVision

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中